Comparing SS&C Technologies (NASDAQ:SSNC) and Medical Transcription Billing (NASDAQ:MTBC)
SS&C Technologies (NASDAQ:SSNC) and Medical Transcription Billing (NASDAQ:MTBC) are both computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.
Volatility & Risk
SS&C Technologies has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500. Comparatively, Medical Transcription Billing has a beta of 1.63, suggesting that its share price is 63% more volatile than the S&P 500.
SS&C Technologies pays an annual dividend of $0.40 per share and has a dividend yield of 0.7%. Medical Transcription Billing does not pay a dividend. SS&C Technologies pays out 15.3% of its earnings in the form of a dividend. SS&C Technologies has raised its dividend for 4 consecutive years.
This table compares SS&C Technologies and Medical Transcription Billing’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Medical Transcription Billing||-6.22%||-10.79%||-8.52%|
Insider and Institutional Ownership
82.7% of SS&C Technologies shares are owned by institutional investors. Comparatively, 6.5% of Medical Transcription Billing shares are owned by institutional investors. 14.5% of SS&C Technologies shares are owned by company insiders. Comparatively, 50.5% of Medical Transcription Billing shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
This is a breakdown of current ratings for SS&C Technologies and Medical Transcription Billing, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Medical Transcription Billing||0||0||2||0||3.00|
SS&C Technologies presently has a consensus target price of $70.54, indicating a potential upside of 21.24%. Medical Transcription Billing has a consensus target price of $6.00, indicating a potential upside of 29.14%. Given Medical Transcription Billing’s higher probable upside, analysts clearly believe Medical Transcription Billing is more favorable than SS&C Technologies.
Valuation & Earnings
This table compares SS&C Technologies and Medical Transcription Billing’s revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|SS&C Technologies||$3.42 billion||4.30||$103.20 million||$2.62||22.21|
|Medical Transcription Billing||$50.55 million||1.11||-$2.14 million||($0.59)||-7.87|
SS&C Technologies has higher revenue and earnings than Medical Transcription Billing. Medical Transcription Billing is trading at a lower price-to-earnings ratio than SS&C Technologies, indicating that it is currently the more affordable of the two stocks.
SS&C Technologies beats Medical Transcription Billing on 14 of the 18 factors compared between the two stocks.
SS&C Technologies Company Profile
SS&C Technologies Holdings, Inc. provides software products and software-enabled services to financial services and healthcare industries in the United States, Canada, rest of the Americas, Europe, the Asia Pacific, and Japan. The company's products and services allow its clients to automate and integrate front-office functions, such as trading and modeling; middle-office functions, including portfolio management and reporting; and back-office functions comprising accounting, transfer agency, compliance, regulatory services, performance measurement, reconciliation, reporting, processing, and clearing. It provides solutions to clients in institutional asset and wealth management, alternative investment management, brokerage, retirement, financial advisory, and financial institutions vertical markets, commercial lenders, real estate investment trusts, corporate treasury groups, insurance companies, pension funds, municipal finance groups, and real estate property managers. The company also offers health care solutions, such as claims adjudication, benefit management, care management, and business intelligence services to health care industry that include pharmacy, healthcare administration, and health optimization solutions, as well as provides professional and products support services. SS&C Technologies Holdings, Inc. was founded in 1986 and is headquartered in Windsor, Connecticut.
Medical Transcription Billing Company Profile
Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform. PracticePro includes practice management software and related tools, which facilitate the day-to-day operation of a medical practice; electronic health records (EHR), which allow its customers to qualify for government incentives; revenue cycle management (RCM) services, which include medical billing, analytics and related services, and mobile Health (mHealth) solutions, including smartphone applications that assist patients and healthcare providers in the provision of healthcare services. The Company offers a clearinghouse service, which allows clients to track claim status.
Receive News & Ratings for SS&C Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SS&C Technologies and related companies with MarketBeat.com's FREE daily email newsletter.